Tetsuya Hamaguchi

机构：Saitama International Medical Center, Saitama Medical University · ORCID：0009-0001-0798-1396

发表论文 338 篇 · 总被引 12321 次 · h-index 45

代表论文

• Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018) (2024 · Journal of Clinical Oncology · 被引 17)
• Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer (2023 · Annals of Surgery · 被引 13)
• A phase III study of combination therapy with everolimus plus lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor (JCOG1901, STARTER-NET). (2025 · Journal of Clinical Oncology · 被引 10)
• PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer: a retrospective study (2023 · BMC Gastroenterology · 被引 9)
• ONO ‐4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer (2025 · Cancer Science · 被引 8)
• Longitudinal ctDNA monitoring and prediction of anti-EGFR rechallenge outcomes in RAS/BRAF wild-type metastatic colorectal cancer (mCRC): The REMARRY & PURSUIT trials. (2025 · Journal of Clinical Oncology · 被引 8)